Home ›
Entities
› academia
› Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions
Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions
Research article (Future Journal of Pharmaceutical Sciences, 2021) · cited 19× · AI/ML
Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions
Summary
Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions is a scholarly article[1].
Key Facts
Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions. Retrieved May 24, 2026, from https://4ort.xyz/entity/computational-insight-to-design-new-potential-hepatitis-c-virus-ns5b-polymerase-inhibitors-with-drug-likeness-and-pharma
MLA“Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/computational-insight-to-design-new-potential-hepatitis-c-virus-ns5b-polymerase-inhibitors-with-drug-likeness-and-pharma.
BibTeX@misc{4ortxyz_computational-insight-to-design-new-potential-hepatitis-c-virus-ns5b-polymerase-inhibitors-with-drug-likeness-and-pharma_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions}}, year = {2026}, url = {https://4ort.xyz/entity/computational-insight-to-design-new-potential-hepatitis-c-virus-ns5b-polymerase-inhibitors-with-drug-likeness-and-pharma}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions — https://4ort.xyz/entity/computational-insight-to-design-new-potential-hepatitis-c-virus-ns5b-polymerase-inhibitors-with-drug-likeness-and-pharma (retrieved 2026-05-24)
